Dr. Bharathi N

Dr. Dr. Bharathi N

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Current Computer-Aided Drug Design
Verified
Journal Article
Closed access
PDF file
DNDr. Bharathi N
Dr. Bharathi N
APArchana Prabahar
Archana Prabahar
SMSudheer Mohammed
Sudheer Mohammed
Background: Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that affects the synovial joints. Nearly 1.6 billion patients are affected by RA worldwide and the incidence of RA is about 0.5 to 1%. Recent studies reveal that immune cell responses and secretion of inflammatory factors are important for the control of RA. Methods: In this study, a set of 402 phytochemicals with anti-inflammatory properties and 16 target proteins related to anti-inflammatory diseases were identified from the literature and they were subjected to network analysis. The protein-protein interaction (PPI) network was constructed using STRING (Search Tool for the Retrieval of Interacting Genes database) database. Visualization of the target gene-phytochemical network and its protein-protein interaction network was conducted using Cytoscape and further analyzed using MCODE (Molecular Complex Detection). The gene ontology and KEGG pathway analysis was performed using DAVID tool. Results: Our results from the network approach indicate that the phytochemicals such as Withanolide, Diosgenin, and Butulin could act as potential substitute for anti-inflammatory drugs, including DMARDs. Genes such as Mitogen-activated protein kinase (MAPK) and Interleukin were found as hub genes and acted as best inhibitors for the target protein pathways. Curcumin, Catechin was also found to be involved in various signaling pathways such as NF-kappa B signaling pathway, ErbB signaling pathway and acted as the best inhibitor along with other candidate phytochemicals. Conclusion: In the current study, we were able to identify Withanolide, Diosgenin, and Butulin as potential anti-inflammatory phytochemicals and determine their association with key pathways involved in RA through network analysis. We hypothesized that natural compounds could significantly contribute to the reduction of dosage, improve the treatment and act as a therapeutic agent for more economical and safer treatment of RA.

1 February 2026 in Current Bioinformatics
Verified
Journal Article
Closed access
PDF file
AJAkhansha John
Akhansha John
SNSaranya Nallusamy
Saranya Nallusamy
Senthil NatesanSenthil Natesan
Senthil Natesan
DNDr. Bharathi N
Dr. Bharathi N
AVAnandhi Venugopal
Anandhi Venugopal
HCHema Bharathi Chinnaswamy
Hema Bharathi Chinnaswamy
Transcriptomics covers the in-depth analysis of RNA molecules in cells or tissues and plays an essential role in understanding cellular functions and disease mechanisms. Advances in spatial transcriptomics (ST) in recent times have revolutionized the field by combining gene expression data with spatial information, enabling the analysis of RNA molecules within their tissue context. The evolution of spatial transcriptomics, particularly the integration of artificial intelligence (AI) in data analysis, and its diverse applications have been found to be superior methods in developmental research. Spatial transcriptomics technologies, along with single-cell RNA sequencing (scRNA-seq), offer unprecedented possibilities to unravel intricate cellular interactions within tissues. It emphasizes the importance of accurate cell localization for in-depth discoveries and developments via highthroughput spatial transcriptome profiling. The integration of artificial intelligence in spatial transcriptomics analysis is a key focus, showcasing its role in detecting spatially variable genes, clustering cell populations, communication analysis, and enhancing data interpretation. The evolution of AI methods tailored for spatial transcriptomics is highlighted, addressing the unique challenges posed by spatially resolved transcriptomic data. Applications of spatial transcriptomics integrated with other omics data, such as genomics, proteomics, and metabolomics, provide a detailed view of molecular processes within tissues and emerge in diverse applications. Integrating spatial transcriptomics with AI represents a transformative approach to understanding tissue architecture and cellular interactions. This innovative synergy not only enhances our understanding of gene expression patterns but also offers a holistic view of molecular processes within tissues, with profound implications for disease mechanisms and therapeutic development.

30 May 2026 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
SGS J Gobika
S J Gobika
DNDr. Bharathi N
Dr. Bharathi N
GSGopinath Samykannu
Gopinath Samykannu
RRRenuka Raman
Renuka Raman
MPMeenakshi Periasamy
Meenakshi Periasamy
KDKavithamani Duraisamy
Kavithamani Duraisamy

8 May 2025 in Plant Science Today
Verified
Journal Article
Open access
PDF file
PUPalanikumar Uma
Palanikumar Uma
SPSeenivasan Prasanna
Seenivasan Prasanna
ATAu Thangavelu
Au Thangavelu
DNDr. Bharathi N
Dr. Bharathi N
VSVichangal Pridiuldi Santhanakrishnan
Vichangal Pridiuldi Santhanakrishnan
RBRajagopal Balasubramanian
Rajagopal Balasubramanian
Snakebite envenoming represents a critical global health challenge, particularly prevalent in regions with limited access to healthcare resources, where venomous snakes pose a significant threat to human populations. Antivenom therapy which mainly rely on antibody production by immunization of large animals with venom components is labour intensive, time consuming and associated with various ethical concerns. Consequently, access to quality and affordable antivenom remains limited in many affected regions with high mortality associated with snakebites. In traditional medicine, many plant species have been ethnobotanically reported for their antivenom properties and are used to neutralize animal toxins. Ribosome-inactivating proteins (RIPs) are a diverse group of toxins found in various organisms, including plants that possess the ability to inhibit protein synthesis by irreversibly damaging the ribosomes. Even though considered to be harmful, the biological role of RIPs has gained increasing attention in recent years due to their potential therapeutic implications. With these insights, this review underscores the potential of RIPs as promising candidates for adjunct treatments in snakebite management strategies. In silico analysis by molecular docking of RIPs with major snake venom proteins resulted in effective binding and shows the interface residues involved in the interaction. This integrative approach enhances our understanding of snakebite pathophysiology, accelerating the development of novel next generation antivenom therapies that are safer and more effective.

6 October 2023 in Research Square
Verified
Preprint
Open access
PDF file
PKPavitra Kathirvel
Pavitra Kathirvel
DNDr. Bharathi N
Dr. Bharathi N
SNSaranya N
Saranya N
MJM Jayakanthan
M Jayakanthan
SVS Vellaikumar
S Vellaikumar
VTVikas Tiwari
Vikas Tiwari
Prosomillet, also known as Broomcorn millet, has emerged as a significant food source for people in temperate and tropical regions due to its drought-resistant nature and rich dietary and therapeutic benefits. However, minor millets remain underutilized, with limited research investigating their nutritional and medicinal properties, particularly their potential as an antiproliferative and antioxidant agent in combating various carcinogenic diseases. This study focuses on the metabolic profiling of Proso Millet using Gas Chromatography-Mass Spectrometry (GC-MS) analysis and the therapeutic potential of the natural metabolite Naringenin as an EGFR cancer cell inhibitor. The metabolites identified were subjected to in-silico analysis, involving molecular docking and virtual screening against the Epidermal Growth Factor Receptor (EGFR) protein (PDB ID: 3w33). A total of 68 phytocompounds from the Prosomillet (ATL-1) were screened, alongside five known FDA-approved cancer inhibitors, to explore the interactions between the cancer protein and the ligands. The docked complex revealed the binding energies between the peptide and the target molecule, suggesting their potential as candidate drugs for cancer treatment. Molecular dynamic simulation studies were carried out on the top-ranked molecule. The in-silico analyses indicate that naringenin has the potential to be a cutting-edge therapeutic candidate for the treatment of human cancer.

4 July 2025 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
VNVidhyashri Nelliyan
Vidhyashri Nelliyan
UDUma D
Uma D
SNSaranya Nallusamy
Saranya Nallusamy
DNDr. Bharathi N
Dr. Bharathi N
UTUma Maheswari Thiyagamoorthy
Uma Maheswari Thiyagamoorthy
RRRaghu Rajasekaran
Raghu Rajasekaran